Renal tumors in solid organ recipients: Clinical and pathologic features

Urologic Oncology: Seminars and Original Investigations

Volumn 31, Issue 2, 2013, Pages 255-258

  Tsivian, Matvey ^a   Caso, Jorge R ^a   Kimura, Masaki ^a   Polascik, Thomas J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Immunosuppression; Outcome; Pathology; Renal cell carcinoma; Transplantation

Indexed keywords

CYCLOSPORIN; MYCOPHENOLIC ACID; PREDNISONE; TACROLIMUS;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ASYMPTOMATIC DISEASE; BODY MASS; CANCER GRADING; CANCER INCIDENCE; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; DEMOGRAPHY; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HEART TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY CANCER; KIDNEY CARCINOMA; KIDNEY SURGERY; KIDNEY TRANSPLANTATION; KIDNEY TUMOR; LIVER TRANSPLANTATION; MALE; MEDICAL HISTORY; ORGAN TRANSPLANTATION; PAPILLARY CARCINOMA; PRIORITY JOURNAL; RENOGRAPHY;

AGED; CARCINOMA, RENAL CELL; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION;

EID: 84875274279     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2010.11.006     Document Type: Article

References (11)

1. Grulich A.E., van Leeuwen M.T., Falster M.O., et al. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: A meta-analysis. Lancet 2007, 370:59-67.
2. Jiang Y., Villeneuve P.J., Wielgosz A., et al. The incidence of cancer in a population-based cohort of Canadian heart transplant recipients. Am J Transplant 2010, 10:637-645.
3. Jiang Y., Villeneuve P.J., Fenton S.S., et al. Liver transplantation and subsequent risk of cancer: Findings from a Canadian cohort study. Liver Transpl 2008, 14:1588-1597.
4. Kasiske B.L., Snyder J.J., Gilbertson D.T., et al. Cancer after kidney transplantation in the United States. Am J Transplant 2004, 4:905-913.
5. Klatte T., Seitz C., Waldert M., et al. Features and outcomes of renal cell carcinoma of native kidneys in renal transplant recipients. BJU Int 2010, 105:1260-1265.
6. Tollefson M.K., Krambeck A.E., Leibovich B.C., et al. Surgical treatment of renal cell carcinoma in the immunocompromised transplant patient. Urology 2010, 75. 1373-17.
7. Neuzillet Y., Lay F., Luccioni A., et al. De novo renal cell carcinoma of native kidney in renal transplant recipients. Cancer 2005, 103:251-257.
8. Tsivian M., Mouraviev V., Albala D.M., et al. Clinical predictors of renal mass pathological features. BJU Int 2010, [in press].
9. Filocamo M.T., Zanazzi M., Li Marzi V., et al. Renal cell carcinoma of native kidney after renal transplantation: Clinical relevance of early detection. Transplant Proc 2009, 41:4197-4201.
10. Elkentaoui H., Robert G., Pasticier G., et al. Therapeutic management of de novo urological malignancy in renal transplant recipients: The experience of the French Department of Urology and Kidney Transplantation from Bordeaux. Urology 2010, 75:126-132.
11. Ianhez L.E., Lucon M., Nahas W.C., et al. Renal cell carcinoma in renal transplant patients. Urology 2007, 69:462-464.